Trevor Bedford on Twitter. (n.d.). Twitter. Retrieved 29 March 2022, from https://twitter.com/trvrb/status/1466076761427304453

Corbevax: All About India’s First Protein Sub-Unit Covid Vaccine to be Given to 12-14 Age Group From Today. (2022, March 16). News18. https://www.news18.com/news/india/corbevax-all-about-indias-first-protein-sub-unit-covid-vaccine-to-be-given-to-12-14-age-group-from-today-4874345.html

Chatterjee, D., Tauzin, A., Marchitto, L., Gong, S. Y., Boutin, M., Bourassa, C., Beaudoin-Bussières, G., Bo, Y., Ding, S., Laumaea, A., Vézina, D., Perreault, J., Gokool, L., Morrisseau, C., Arlotto, P., Fournier, É., Guilbault, A., Delisle, B., Levade, I., … Finzi, A. (2022). SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses. Cell Reports, 0(0). https://doi.org/10.1016/j.celrep.2022.110429

Hall, V. G., Ferreira, V. H., Wood, H., Ierullo, M., Majchrzak-Kita, B., Manguiat, K., Robinson, A., Kulasingam, V., Humar, A., & Kumar, D. (2022). Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses. Nature Immunology, 1–6. https://doi.org/10.1038/s41590-021-01126-6

Taylor, L. (2022). Covid-19: CoronaVac immunity is strongest after boosting with a different vaccine. BMJ, 376, o210. https://doi.org/10.1136/bmj.o210

Dolgin, E. (2022). Omicron thwarts some of the world’s most-used COVID vaccines. Nature. https://doi.org/10.1038/d41586-022-00079-6

Iacobucci, G. (2022). Covid-19: Fourth vaccine doses—who needs them and why? BMJ, 376, o30. https://doi.org/10.1136/bmj.o30

Richterman, A., Scott, J., & Cevik, M. (2021). Covid-19 vaccines, immunity, and boosters. BMJ, 375, n3105. https://doi.org/10.1136/bmj.n3105

Reuters. (2021, December 20). Moderna says booster produces strong antibody response to Omicron. The Guardian. https://www.theguardian.com/world/2021/dec/20/moderna-booster-strong-antibody-response-omicron-covid-vaccine-variant

Mahase, E. (2021). Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds. BMJ, 375, n3011. https://doi.org/10.1136/bmj.n3011

Thiruvengadam, R., Awasthi, A., Medigeshi, G., Bhattacharya, S., Mani, S., Sivasubbu, S., Shrivastava, T., Samal, S., Murugesan, D. R., Desiraju, B. K., Kshetrapal, P., Pandey, R., Scaria, V., Malik, P. K., Taneja, J., Binayke, A., Vohra, T., Zaheer, A., Rathore, D., … Garg, P. K. (2021). Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: A test-negative, case-control study and a mechanistic study of post-vaccination immune responses. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00680-0

Reardon, S. (2021). Cuba’s bet on home-grown COVID vaccines is paying off. Nature. https://doi.org/10.1038/d41586-021-03470-x

Breen, Liz, and Sarah Schiffling. ‘The UK’s Speedy COVID-19 Vaccine Rollout: Surprise Success or Planned Perfection?’ The Conversation. Accessed 15 November 2021. http://theconversation.com/the-uks-speedy-covid-19-vaccine-rollout-surprise-success-or-planned-perfection-155922.

Covering COVID-19 vaccine boosters: 4 tips and a timeline. (n.d.). Retrieved October 25, 2021, from https://journalistsresource.org/home/covid-19-boosters-tip-sheet/

Thushan de Silva on Twitter. (n.d.). Twitter. Retrieved 29 July 2021, from https://twitter.com/Thushan_deSilva/status/1418511974435115011

magazine, H. L., Nature. (n.d.). Delaying a COVID Vaccine’s Second Dose Boosts Immune Response in the Elderly. Scientific American. Retrieved 30 May 2021, from https://www.scientificamerican.com/article/delaying-a-covid-vaccine-rsquo-s-second-dose-boosts-immune-response-in-the-elderly/

In-Depth: Delaying the second COVID-19 vaccine dose has benefits and drawbacks. (2021, May 20). KGTV. https://www.10news.com/news/in-depth/in-depth-delaying-the-second-covid-19-vaccine-dose-has-benefits-and-drawbacks

Deutsch, J., & Barigazzi, J. (2021, April 21). EU preparing legal case against AstraZeneca over vaccine shortfalls. POLITICO. https://www.politico.eu/article/eu-preparing-legal-case-against-astrazeneca-over-vaccine-shortfalls/

Felipe, L. S., Vercruysse, T., Sharma, S., Ma, J., Lemmens, V., Looveren, D. van, Javarappa, M. P. A., Boudewijns, R., Malengier-Devlies, B., Kaptein, S. F., Liesenborghs, L., Keyzer, C. D., Bervoets, L., Rasulova, M., Seldeslachts, L., Jansen, S., Yakass, M. B., Quaye, O., Li, L.-H., … Dallmeier, K. (2020). A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate. BioRxiv, 2020.07.08.193045. https://doi.org/10.1101/2020.07.08.193045

Wow. Dose response relationship of sorts.